Cargando…

DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells

Defining new therapeutic strategies to overcome therapy resistance due to tumor heterogeneity in colon cancer is challenging. One option is to explore the molecular profile of aggressive disseminating tumor cells. The cytoskeleton-associated Death-associated protein kinase (DAPK) is involved in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivanovska, Jelena, Zlobec, Inti, Forster, Stefan, Karamitopoulou, Eva, Dawson, Heather, Koelzer, Viktor Hendrik, Agaimy, Abbas, Garreis, Fabian, Söder, Stephan, Laqua, William, Lugli, Alessandro, Hartmann, Arndt, Rau, Tilman T., Schneider-Stock, Regine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742210/ https://www.ncbi.nlm.nih.gov/pubmed/26405175

Ejemplares similares

Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells
por: Ivanovska, Jelena, et al.
Publicado: (2017)

Tumor Budding in Upper Gastrointestinal Carcinomas
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
por: Wartenberg, Martin, et al.
Publicado: (2015)

Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer
por: Sokol, Lena, et al.
Publicado: (2015)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
por: Galván, José A., et al.
Publicado: (2014)

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013)

Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types
por: Zlobec, Inti, et al.
Publicado: (2013)

Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer
por: Zlobec, Inti, et al.
Publicado: (2021)

Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012)

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study
por: Koelzer, Viktor H, et al.
Publicado: (2015)

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
por: Blank, Annika, et al.
Publicado: (2019)

Role of tumor size in the pre-operative management of rectal cancer patients
por: Zlobec, Inti, et al.
Publicado: (2010)

Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2013)

Tumour budding and its clinical implications in gastrointestinal cancers
por: Zlobec, Inti, et al.
Publicado: (2020)

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
por: Koelzer, V H, et al.
Publicado: (2013)

Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer
por: Georges, Laurent M. C., et al.
Publicado: (2019)

Cytokeratin‐based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience
por: Koelzer, Viktor H, et al.
Publicado: (2017)

Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients
por: Zlobec, Inti, et al.
Publicado: (2012)

DAPK1 loss triggers tumor invasion in colorectal tumor cells
por: Steinmann, Sara, et al.
Publicado: (2019)

Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study
por: Karamitopoulou, Eva, et al.
Publicado: (2020)

Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer
por: Bokhorst, John-Melle, et al.
Publicado: (2023)

Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
por: Blank, Annika, et al.
Publicado: (2018)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
por: Zlobec, I, et al.
Publicado: (2014)

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

Molecular and Pathogenetic Aspects of Tumor Budding in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2015)

Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients
por: Nolte, Sarah, et al.
Publicado: (2017)

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015)

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

The battle for prognosis at the invasive front of colorectal cancer
por: Lugli, Alessandro, et al.
Publicado: (2020)

Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer
por: Karamitopoulou, Eva
Publicado: (2013)

Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity
por: Sadozai, Hassan, et al.
Publicado: (2021)

Immunophenotypic profile of tumor buds in breast cancer
por: Laedrach, C., et al.
Publicado: (2017)

Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19
por: Koelzer, Viktor Hendrik, et al.
Publicado: (2022)

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
por: Lugli, A, et al.
Publicado: (2009)

Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients
por: Helbling, Melina, et al.
Publicado: (2014)

Tumor Budding beim kolorektalen Karzinom – Informationen zur klinischen Anwendung und Anleitung zur praktischen Bestimmung
por: Müller, Felix, et al.
Publicado: (2021)

Editorial: Computational Pathology
por: Bozorgtabar, Behzad, et al.
Publicado: (2020)

TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer
por: Zlobec, Inti, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_psd9a14qck1tnvsncbon528b2v